Tien Liang Biotech Co

Tien Liang Biotech Co PEG

PEG Ratio (Price/Earnings-to-Growth) of Tien Liang Biotech Co (4127.TWO) as of Nov 19, 2026.

PEG

-

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Tien Liang Biotech Co is 2026 - . PEG Ratio (Price/Earnings-to-Growth) of Tien Liang Biotech Co was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Tien Liang Biotech Co Stock analysis

What does Tien Liang Biotech Co do? Tien Liang BioTech Co. Ltd. manufactures and sells Chinese herbal and western medicine, including active pharmaceutical ingredients (APIs), biopharmaceuticals, and traditional Chinese medicines. The company imports, wholesales, and retails western medicines domestically. Its products are distributed within the domestic market, targeting healthcare providers and consumers seeking traditional and modern pharmaceutical solutions. The firm's revenue streams come from the sale of manufactured medicines, APIs, biopharmaceuticals, and retail distribution of western medicines. Domestic market sales form the core of its business, with no mention of international distribution channels. The company serves both the traditional Chinese medicine segment and the modern pharmaceutical segment through its comprehensive product portfolio. Tien Liang BioTech operates within the pharmaceutical manufacturing and distribution sector, focusing on domestic sales of herbal, western, and biopharmaceutical products. Its business model integrates manufacturing, import, wholesale, and retail operations to serve the local healthcare market. Tien Liang Biotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Tien Liang Biotech Co stock

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Tien Liang Biotech Co since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Tien Liang Biotech Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Tien Liang Biotech Co

All Key Metrics — Tien Liang Biotech Co